Saint-Gilles Pharma SRL
Saint-Gilles Pharma reported total assets of 556,225 € at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Jul 2026).
The score of Saint-Gilles Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +11 % Total assets -29 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Saint-Gilles Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 10,615 € | ||||
| Equity | 252,269 € | ||||
| Cash | 273,760 € | ||||
| EBITDA | 75,514 € | ||||
| Total assets | 556,225 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 26 Jul 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
Saint-Gilles Pharma's financial analysis
- Solvency45.4%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Saint-Gilles Pharma
Saint-Gilles Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0712.909.319
- VAT number
- BE0712909319
- Peppol
- Registered · 0208:0712909319 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Nov 2018
- Registered office
- 4000 Liège
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Saint-Gilles Pharma (SRL) has been based in Liège since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 10,615 € and equity of 252,269 €; its revenue is not published. Its solvency stands at 45.4%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Saint-Gilles Pharma
Companies in the same business, of comparable size and area, outside its group.
- Kapelle Apotheek Retail sale of pharmaceutical products Aartselaar · balance sheet 556,476 €
- Apotheek van Ghyseghem Retail sale of pharmaceutical products Antwerp · balance sheet 555,938 €
- Farma - Bovan Retail sale of pharmaceutical products Sint-Niklaas · balance sheet 411,627 €
- Pharmacie Mosseray Retail sale of pharmaceutical products Anhée · balance sheet 557,870 €
- VAN EYCKEN Apotheek-Optiek Retail sale of pharmaceutical products Diest · balance sheet 553,302 €
- Naveau-Smeets Retail sale of pharmaceutical products Lint · balance sheet 552,659 €
- De Nil Retail sale of pharmaceutical products Dendermonde · balance sheet 551,344 €
- Stragier Retail sale of pharmaceutical products Ath · balance sheet 562,496 €
Frequently asked questions about Saint-Gilles Pharma
What is the revenue of Saint-Gilles Pharma?
Saint-Gilles Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Saint-Gilles Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0712909319 for Saint-Gilles Pharma, if the company is VAT-registered. Its company number (CBE) is 0712.909.319.
Where is the registered office of Saint-Gilles Pharma?
According to the CBE register, the registered office of Saint-Gilles Pharma is in 4000 Liège.
What is the equity of Saint-Gilles Pharma?
At the close of the 2025 financial year, the equity of Saint-Gilles Pharma amounts to 252,269 €, a solvency of 45.4% of total assets.
Who manages Saint-Gilles Pharma?
The register lists 1 active mandates at Saint-Gilles Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Saint-Gilles Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →